Nabriva Therapeutics plc·4

Apr 2, 5:47 PM ET

Schranz Jennifer 4

4 · Nabriva Therapeutics plc · Filed Apr 2, 2020

Insider Transaction Report

Form 4
Period: 2020-03-31
Schranz Jennifer
Chief Medical Officer
Transactions
  • Tax Payment

    Ordinary Shares

    2020-03-31$0.57/sh301$173169,648 total

Documents

1 file
  • 4
    a4.xmlPrimary

    4